Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Harnessing microbiota to kill a pathogen: the sweet tooth of Clostridium difficile.

Literature DB >> 24603797

Harnessing microbiota to kill a pathogen: the sweet tooth of Clostridium difficile.

Ruth E Ley¹.

Abstract

Entities: Species

Mesh：

Substances：

Year: 2014 PMID： 24603797 DOI： 10.1038/nm.3494

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

14 in total

1. Reprogramming microbes to be pathogen-seeking killers.

Authors: In Young Hwang; Mui Hua Tan; Elvin Koh; Chun Loong Ho; Chueh Loo Poh; Matthew Wook Chang
Journal: ACS Synth Biol Date: 2013-09-13 Impact factor: 5.110

Review 2. Bio-inspired, bioengineered and biomimetic drug delivery carriers.

Authors: Jin-Wook Yoo; Darrell J Irvine; Dennis E Discher; Samir Mitragotri
Journal: Nat Rev Drug Discov Date: 2011-07-01 Impact factor: 84.694

Review 3. Fecal microbiota transplantation and emerging applications.

Authors: Thomas J Borody; Alexander Khoruts
Journal: Nat Rev Gastroenterol Hepatol Date: 2011-12-20 Impact factor: 46.802

4. Duodenal infusion of donor feces for recurrent Clostridium difficile.

Authors: Els van Nood; Anne Vrieze; Max Nieuwdorp; Susana Fuentes; Erwin G Zoetendal; Willem M de Vos; Caroline E Visser; Ed J Kuijper; Joep F W M Bartelsman; Jan G P Tijssen; Peter Speelman; Marcel G W Dijkgraaf; Josbert J Keller
Journal: N Engl J Med Date: 2013-01-16 Impact factor: 91.245

5. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

Authors: L V McFarland; C M Surawicz; R N Greenberg; R Fekety; G W Elmer; K A Moyer; S A Melcher; K E Bowen; J L Cox; Z Noorani
Journal: JAMA Date: 1994 Jun 22-29 Impact factor: 56.272

6. The convergence of carbohydrate active gene repertoires in human gut microbes.

Authors: Catherine A Lozupone; Micah Hamady; Brandi L Cantarel; Pedro M Coutinho; Bernard Henrissat; Jeffrey I Gordon; Rob Knight
Journal: Proc Natl Acad Sci U S A Date: 2008-09-19 Impact factor: 11.205

7. Structure, function and diversity of the healthy human microbiome.

Authors:
Journal: Nature Date: 2012-06-13 Impact factor: 49.962

8. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens.

Authors: Katharine M Ng; Jessica A Ferreyra; Steven K Higginbottom; Jonathan B Lynch; Purna C Kashyap; Smita Gopinath; Natasha Naidu; Biswa Choudhury; Bart C Weimer; Denise M Monack; Justin L Sonnenburg
Journal: Nature Date: 2013-09-01 Impact factor: 49.962

9. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.

Authors: Les Dethlefsen; Sue Huse; Mitchell L Sogin; David A Relman
Journal: PLoS Biol Date: 2008-11-18 Impact factor: 8.029

10. Fecal transplantation for the treatment of recurrent clostridium difficile infection.

Authors: Zeid Karadsheh; Sachin Sule
Journal: N Am J Med Sci Date: 2013-06

13 in total

Review 1. Infectious diarrhea: an overview.

Authors: Brandon Dickinson; Christina M Surawicz
Journal: Curr Gastroenterol Rep Date: 2014-08

2. Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease.

Authors: Jihong Li; Bruce A McClane
Journal: Infect Immun Date: 2014-08-18 Impact factor: 3.441

Harnessing microbiota to kill a pathogen: the sweet tooth of Clostridium difficile.

1. Reprogramming microbes to be pathogen-seeking killers.

Review 2. Bio-inspired, bioengineered and biomimetic drug delivery carriers.

Review 3. Fecal microbiota transplantation and emerging applications.

4. Duodenal infusion of donor feces for recurrent Clostridium difficile.

5. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

6. The convergence of carbohydrate active gene repertoires in human gut microbes.

7. Structure, function and diversity of the healthy human microbiome.

8. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens.

9. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.

10. Fecal transplantation for the treatment of recurrent clostridium difficile infection.

Review 1. Infectious diarrhea: an overview.

2. Contributions of NanI sialidase to Caco-2 cell adherence by Clostridium perfringens type A and C strains causing human intestinal disease.

3. NanR Regulates nanI Sialidase Expression by Clostridium perfringens F4969, a Human Enteropathogenic Strain.

4. Metabolism of sialic acid by Bifidobacterium breve UCC2003.

Review 5. Gut microbiota-mediated protection against diarrheal infections.

6. Center Variation in Intestinal Microbiota Prior to Late-Onset Sepsis in Preterm Infants.

7. Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection.

Review 8. Clostridium perfringens Sialidases: Potential Contributors to Intestinal Pathogenesis and Therapeutic Targets.

Review 9. Colonization Resistance of the Gut Microbiota against Clostridium difficile.

Review 10. Disruption of the Gut Ecosystem by Antibiotics.